FDA Clears RedDrop Dx, Inc.’s Blood Collection Device, RedDrop One
Fort Collins, CO, March 22, 2024 (GLOBE NEWSWIRE) -- RedDrop Dx , Inc., Innosphere Ventures Client Company, is pleased to announce that its innovative blood collection device, RedDrop One, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for prescription use.
- Fort Collins, CO, March 22, 2024 (GLOBE NEWSWIRE) -- RedDrop Dx , Inc., Innosphere Ventures Client Company, is pleased to announce that its innovative blood collection device, RedDrop One, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for prescription use.
- This clearance marks a significant step forward for RedDrop Dx in enhancing blood collection technology and patient care practices.
- RedDrop One offers several key advantages over traditional blood collection methods, including the ability to collect a larger volume of blood more easily, with increased reliability and reduced discomfort for the user.
- The device is designed to meet the needs of both patients and healthcare providers by offering a more efficient and less painful blood collection experience.